The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Initiatives

News and Events

Webinar: RADx Tech Accessible Tests Program

thumbnail

Webinar: RADx Tech Accessible Tests Program

In the Spring of 2022, RADx Tech launched a new program aimed at making COVID-19 home tests more accessible. The program applied the RADx Tech process to evaluate and support test companies, but at the same time, required new unique resources and capabilities. Learn about this program’s origin, stakeholders, and the process that is delivering results.

Speakers: 
Brian Walsh
RADx Tech Accessibility Program Manager

Sarah Farmer
Director of Testing and Evaluation at the Center for Advanced Communications Policy at Georgia Tech, and the Managing Director of Georgia Tech’s HomeLab

Susan McDonald
Director Human Factors and User Research, Veranex Solution

David Copeland
Director Human Centered Design, Veranex Solution

When:
January 24, 2023 
2PM ET

Watch the Recording >

Download the Slides >

If you need assistance registering for this webinar please call 617-643-3800 or email cimitcommunications@partners.org.

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.